Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21888993 | 0.87 | AOC3 (1.00) | AOC3 | |
| SCHEMBL21889070 | 0.85 | AOC3 (1.00) | AOC3 | |
| SCHEMBL25832182 | 0.83 | AOC3 (0.71) | AOC3 | |
| SCHEMBL21889018 | 0.82 | AOC3 (1.00) | AOC3 | |
| SCHEMBL21889007 | 0.82 | AOC3 (1.00) | AOC3 | |
| SCHEMBL21889069 | 0.82 | AOC3 (1.00) | AOC3 | |
| SCHEMBL21915133 | 0.81 | AOC3 (0.68) | AOC3 | |
| SCHEMBL21889008 | 0.81 | AOC3 (1.00) | AOC3 | |
| SCHEMBL21889073 | 0.80 | AOC3 (1.00) | AOC3 | |
| SCHEMBL25841776 | 0.80 | AOC3 (0.87) | AOC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3626699-B1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2023-07-12 | — | — | EP | disclosed |
| US-20220024880-A1 | PROCESS ROUTE OF COMPOUND OF FORMULA (IV), CRYSTAL FORM AND PREPARATION METHOD THEREFOR | SHANDONG DANHONG PHARMACEUTICAL CO., LTD. (CN) | 2022-01-27 | — | — | US | disclosed |
| EP-3901143-A1 | PROCESS ROUTE OF COMPOUND OF FORMULA (IV), CRYSTAL FORM AND PREPARATION METHOD THEREFOR | Shangdong Danhong Pharmaceutical Co., Ltd. (CN) | 2021-10-27 | — | — | EP | disclosed |
| US-20210198220-A1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-07-01 | — | — | US | disclosed |
| US-11001563-B2 | SSAO inhibitor | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-05-11 | — | — | US | disclosed |
| WO-2020125776-A1 | PROCESS ROUTE OF COMPOUND OF FORMULA (IV), CRYSTAL FORM AND PREPARATION METHOD THEREFOR | 山东丹红制药有限公司 | 2020-06-25 | — | — | WO | disclosed |
| US-20200115352-A1 | SSAO INHIBITOR | SHANDONG DANHONG PHARMACEUTICAL CO., LTD. | 2020-04-16 | — | — | US | disclosed |
| EP-3626699-A1 | SSAO INHIBITOR | Shandong Danhong Pharmaceutical Co., Ltd. (CN) | 2020-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001563-B2 | SSAO inhibitor | SSB, ASAH2, AOX1 | AOC3 53/4885 |
| US-20210198220-A1 | SSAO INHIBITOR | SSB, ASAH2, AOX1 | AOC3 53/4885 |
| US-20200115352-A1 | SSAO INHIBITOR | SSB, ASAH2, AOX1 | AOC3 53/4885 |
| US-20220024880-A1 | PROCESS ROUTE OF COMPOUND OF FORMULA (IV), CRYSTAL FORM AND PREPARATION METHOD THEREFOR | CYP4F11, CYP4A11, CYP4F8 | AOC3 986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.